"In light of the Company’s inability to presently predict the duration of the stop ship, the Company believes that it will be ...

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the medical devices & supplies - imaging, diagnostics ...

A study published in the American Journal of Roentgenology demonstrated the powerful potential of AI-powered mammography, ...

Hologic said it expects to close an unspecified number of international facilities as it discontinues certain products and shifts strategy in one of its diagnostics businesses. The women’s ...

The global Gynecological Devices market is expanding, supported by the higher prevalence of diseases like PCOS, uterine ...

Hologic has put forward more data bolstering the use of its artificial intelligence programs for detecting breast cancer through mammography. | Hologic put forward another study that bolsters the use ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

Hologic’s AI-Powered Mammography Technology “At Hologic, we are constantly pushing ourselves to innovate and enhance the quality and reliability of our technologies,” said M ...

Hologic (HOLX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Between 2016 and 2019, researchers at a top-tier medical facility conducted 7,500 digital breast tomosynthesis (3D ...

In the fourth quarter of fiscal 2025, Diagnostics revenues increased 1.5% in constant currency (CC), driven by higher core ...

Hologic stock (NASDAQ: HOLX) has rallied around 83% over recent weeks (vs. about a 40% gain in the S&P 500) to its current level of $53 after falling to a low of $29 in late March as a rapid increase ...